logo

For the Inventor, By the Inventor

North Ryde, Australia

Biosceptre (Aust) Pty Ltd

Calculating rank
USPTO Granted Patents = 17

% Expired Patents = 11.8

Trademarks = 2

Forward Citations = 51

Loading Chart...
Loading Chart...

10 inventors (with patents filed for the assignee):

goldMedal Julian Alexander Barden (16 out of 32 patents)

silverMedal Angus Gidley-Baird (10 out of 25 patents)

bronzeMedal Philip Jones (4 out of 13 patents)

4.  Neil Brewis (4 out of 5 patents)

5.  Steven Grant (4 out of 20 patents)

6.  Xiaojuan Gong (2 out of 3 patents)

7.  Minoo Jalili Moghaddam (2 out of 14 patents)

8.  Justin Taylor Coombs (1 out of 1 patent)

9.  Simon Charles Barry (1 out of 1 patent)

10.  Timothy John Sadlon (1 out of 1 patent)


17 patents:

1. 12129295 - Anti P2X7 receptor antibodies and fragments thereof (2024-10-29),
2. 12121539 - Chimeric antigen receptors and uses thereof (2024-10-22),
3. 12097265 - Cytotoxic particles for targeting P2X7 receptor (2024-09-24),
4. 11260131 - Cytotoxic particles for targeting P2X7 receptor (2022-03-01),
5. 10988532 - Anti P2Xreceptor antibodies and fragments thereof (2021-04-27),
6. 10597451 - Methods of treating cancer with a P2X7 peptide (2020-03-24),
7. 10543262 - Combination therapy utilizing P2X7 peptides (2020-01-28),
8. 10450380 - Polypeptide immunogen for generating an antibody to non-functional P2X7 receptor (2019-10-22),
9. 10245308 - Combination therapy utilizing P2X7 peptides (2019-04-02),
10. 10238716 - [object Object] (2019-03-26),
11. 10053508 - Anti P2X7 receptor antibodies and fragments thereof (2018-08-21),
12. 9944701 - Methods of treating cancer with antibodies that bind P2X7 receptors (2018-04-17),
13. 9688771 - [object Object] (2017-06-27),
14. 9663584 - Antibodies to non-functional P2X7 receptor (2017-05-30),
15. 9566318 - Combination therapy (2017-02-14),
Company Overview
Biosceptre (Aust) Pty Ltd is an innovative biotechnology company based in North Ryde, Australia, specializing in the development of advanced therapeutic solutions. The organization focuses on harnessing proprietary technologies to create novel treatments, particularly in the field of cancer immunotherapy. With a commitment to addressing unmet medical needs, Biosceptre aims to improve patient outcomes through its cutting-edge research and development efforts in the biopharmaceutical sector.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

17 Patents

#5 in North Ryde

#213 in Australia

#35,974 in the World

North Ryde, AU
North Ryde, Australia

Biosceptre (Aust) Pty Ltd

Forward Citations = 51

10 inventors:

goldMedal Julian Alexander Barden (16 out of 32 patents)

silverMedal Angus Gidley-Baird (10 out of 25 patents)

bronzeMedal Philip Jones (4 out of 13 patents)

4.  Neil Brewis (4 out of 5 patents)

5.  Steven Grant (4 out of 20 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Biosceptre (Aust) Pty Ltd. Retrieved from https://idiyas.com/company/biosceptre-aust-pty

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…